ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,792,871 | +72.1% | 261,733 | +160.5% | 0.00% | – |
| Q2 2023 | $1,041,739 | -6.6% | 100,457 | -27.2% | 0.00% | – |
| Q1 2023 | $1,115,797 | +147492.2% | 137,923 | +187.2% | 0.00% | – |
| Q4 2022 | $756 | -99.9% | 48,017 | 0.0% | 0.00% | – |
| Q3 2022 | $756,000 | +125.0% | 48,017 | +157.6% | 0.00% | – |
| Q3 2021 | $336,000 | +2.8% | 18,640 | 0.0% | 0.00% | – |
| Q2 2021 | $327,000 | -30.4% | 18,640 | 0.0% | 0.00% | – |
| Q1 2021 | $470,000 | +288.4% | 18,640 | 0.0% | 0.00% | – |
| Q4 2020 | $121,000 | +152.1% | 18,640 | +0.0% | 0.00% | – |
| Q3 2020 | $48,000 | +166.7% | 18,632 | +63.3% | 0.00% | – |
| Q2 2020 | $18,000 | +50.0% | 11,413 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -45.5% | 11,413 | 0.0% | 0.00% | – |
| Q4 2019 | $22,000 | -96.3% | 11,413 | -97.9% | 0.00% | – |
| Q3 2019 | $588,000 | -70.2% | 544,725 | -39.5% | 0.00% | -100.0% |
| Q2 2019 | $1,973,000 | -56.0% | 901,043 | +20.3% | 0.00% | -50.0% |
| Q1 2019 | $4,487,000 | +24.0% | 749,127 | +53.0% | 0.00% | 0.0% |
| Q4 2018 | $3,618,000 | +4.4% | 489,516 | +105.2% | 0.00% | +100.0% |
| Q3 2018 | $3,464,000 | +1003.2% | 238,553 | +1417.8% | 0.00% | – |
| Q2 2018 | $314,000 | +14.2% | 15,717 | 0.0% | 0.00% | – |
| Q1 2018 | $275,000 | -29.1% | 15,717 | 0.0% | 0.00% | – |
| Q4 2017 | $388,000 | – | 15,717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |